Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.26
Delayed Data
As of 4:00pm ET
 -0.04 / -3.08%
Today’s Change
1.26
Today|||52-Week Range
5.70
-27.59%
Year-to-Date

Today’s Trading

Previous close1.30
Today’s open1.30
Day’s range1.26 - 1.31
Volume260,213
Average volume (3 months)166,457
Market cap$20.1M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)+67.69%
Earnings growth (this year)-412.20%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+37.82%
P/E ratioNM
Price/Sales0.75
Price/Book0.33

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc+0.15+2.26%
PPHMPPeregrine Pharmaceut...+0.16+0.63%
PULMPulmatrix Inc-0.05-3.31%
PRPHProPhase Labs Inc+0.01+0.44%
Data as of 4:00pm ET, 12/13/2017

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$2.06
Annual revenue (last year)$33.7M
Annual profit (last year)-$24.5M
Net profit margin-72.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts